IMR Press / FBL / Volume 13 / Issue 8 / DOI: 10.2741/2913

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Mitochondria in multiple sclerosis
Show Less
1 Department of Surgery, Davis Heart and Lung Research Institute and Institute of Mitochondrial Biology, The Ohio State University, Columbus, Ohio, USA
2 Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran

*Author to whom correspondence should be addressed.

 

Front. Biosci. (Landmark Ed) 2008, 13(8), 3116–3126; https://doi.org/10.2741/2913
Published: 1 January 2008
Abstract

Multiple sclerosis (MS) is a neurological disorder of the central nervous system characterized by demyelination and neurodegeneration. Although the pathogenesis of MS is not completely understood, various studies suggest that immune-mediated loss of myelin and mitochondrial dysfunction are associated with the disease. Mitochondria are one of the main cellular sources of reactive oxygen species (ROS) and reactive nitrogen species (RNS) and play a pivotal role in many neuro-pathological conditions. Mitochondrial dysfunction leading to excessive production of ROS and RNS plays a significant role in the pathogenesis of MS, particularly in loss of myelin/oligodendrocyte complex. The present review summarizes critical role of mitochondria in the pathogenesis of MS. Further understanding of the role of mitochondria in MS may provide rationale for novel approaches to this disease and development of novel therapeutic maneuvers.

Share
Back to top